These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1358622)

  • 1. Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidence.
    Keisu M; Ekman E
    Eur J Clin Pharmacol; 1992; 43(3):215-8. PubMed ID: 1358622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish Drug Monitoring System and a case-control study.
    Keisu M; Ekman E; Wiholm BE
    Eur J Clin Pharmacol; 1992; 43(3):211-4. PubMed ID: 1358621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
    Kuipers EJ; Vellenga E; de Wolf JT; Hazenberg BP
    J Rheumatol; 1992 Apr; 19(4):621-2. PubMed ID: 1350640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine-induced agranulocytosis.
    Jacobson IM; Kelsey PB; Blyden GT; Demirjian ZN; Isselbacher KJ
    Am J Gastroenterol; 1985 Feb; 80(2):118-21. PubMed ID: 2857524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine induced agranulocytosis.
    Hutchinson D; Wyld PJ
    N Z Med J; 1983 Jul; 96(735):520-1. PubMed ID: 6137796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor.
    Roddie P; Dorrance H; Cook MK; Rainey JB
    Aliment Pharmacol Ther; 1995 Dec; 9(6):711-2. PubMed ID: 8824661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of drug-induced agranulocytosis with recombinant GM-CSF.
    Palmblad J; Jonson B; Kanerud L
    J Intern Med; 1990 Nov; 228(5):537-9. PubMed ID: 1979344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Salazopyrine-induced agranulocytosis: clinical picture and incidence].
    Lakartidningen; 1991 Mar; 88(12):1117-8. PubMed ID: 1673165
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
    Farr M; Symmons DP; Blake DR; Bacon PA
    Ann Rheum Dis; 1986 Sep; 45(9):761-4. PubMed ID: 2876683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agranulocytosis associated with sulphasalazine therapy.
    Cochrane P; Atkins P; Ehsanullah S
    Postgrad Med J; 1973 Sep; 49(575):669-72. PubMed ID: 4151092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agranulocytosis associated with sulfasalazine.
    Dery CL; Schwinghammer TL
    Drug Intell Clin Pharm; 1988 Feb; 22(2):139-42. PubMed ID: 2894966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.
    Murphy PT; O'Donnell JR
    Ir J Med Sci; 1990 Jun; 159(6):195. PubMed ID: 1977725
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor for sulfasalazine-induced agranulocytosis.
    Gales BJ; Gales MA
    Ann Pharmacother; 1993 Sep; 27(9):1052-4. PubMed ID: 7693069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic mechanism in sulphasalazine-induced agranulocytosis.
    Victorino RM; Maria VA; de Deus J
    Acta Haematol; 1990; 84(2):111. PubMed ID: 1977273
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulphasalazine induced agranulocytosis revisited.
    Murphy PT; Casey MC
    Ir Med J; 1998 Dec; 91(6):216. PubMed ID: 10069135
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL; Slater DN
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulphasalazine-induced agranulocytosis successfully treated with filgrastim.
    Crawford GP; Laurence BL
    Aust N Z J Med; 1996 Apr; 26(2):240. PubMed ID: 8744630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.